Subtype

Prostate Neoplasm

Non-malignant1,453 active trials24 approved drugs58 evidence items

NCIt: C3343
MeSH: D011471

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (260)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 260 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player.
Shu Li, Chuanfan Zhong, Yixun Zhang et al. · Transl Oncol · Oct 1, 2026 · PMID 42685612 · candidate dictionary pubmed
Single-cell and spatial transcriptomic profiling identifies a fibroblast-like endothelial state and the MDK-NCL signaling axis in prostate cancer microenvironment remodeling.
Ruiang Wang, Yifan Li, Xiaoxiang Wang · Transl Oncol · Oct 1, 2026 · PMID 42669284 · candidate dictionary pubmed
Comparative assessment of METastasis Reporting and Data System for Prostate Cancer versus Prostate Cancer Clinical Trials Working Group 3 Criteria in assessing treatment response in patients with metastatic castration-resistant prostate cancer.
Luca Russo, Ossian Longoria, Silvia Bottazzi et al. · Eur Urol Open Sci · Oct 1, 2026 · PMID 42668444 · candidate dictionary pubmed
Decoding the metabolic‑immune crosstalk: The role of glutamine and ammonium reprogramming in prostate cancer immune evasion (Review).
Peilong Wang, Xiaoran Li, Teng Ma et al. · Oncol Rep · Oct 1, 2026 · PMID 42663286 · candidate dictionary pubmed
Co-treatment with pyrvinium pamoate and hispidulin potently reduces stemness and promotes mitochondrial apoptosis in prostate cancer cells.
Riza Serttas, Suat Erdogan · Cytotechnology · Oct 1, 2026 · PMID 42643730 · candidate dictionary pubmed
[Retracted] 2',4'-dihydroxychalcone, a flavonoid isolated from Herba oxytropis, suppresses PC-3 human prostate cancer cell growth by induction of apoptosis.
Yuqing Sheng, Mingchang Zou, Yan Wang et al. · Oncol Lett · Oct 1, 2026 · PMID 42621497

· candidate dictionary

pubmed

PCDHGB2 promotes docetaxel resistance in prostate cancer via TR4-mediated activation of the HIF-1α/VEGFA pathway.

Fanyu Meng, Xinyi Zhou, Yong Qin et al. · Cytotechnology · Oct 1, 2026 · PMID 42621174 · candidate dictionary pubmed

Why immunotherapy fails in prostate cancer and what comes next.

Chuzhong Wei, Qiang Wei, Shi Qiu · BJU Int · Oct 1, 2026 · PMID 42581830 · candidate dictionary pubmed

Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.

Karim Obeid, Mark Konijnenberg, Ekaterina Bezverkhniaia et al. · Biomed Pharmacother · Oct 1, 2026 · PMID 42700618 · candidate dictionary pubmed

Systemic therapies in prostate cancer: A field in transformation.

Clara Hwang · Urol Oncol · Oct 1, 2026 · PMID 42728123 · candidate dictionary pubmed

Post-translational modifications in prostate cancer: coordinated oncogenic networks and clinical implications.

Huan Ren, Xuanji Li, Zhiliang Jiang et al. · Biochim Biophys Acta Rev Cancer · Oct 1, 2026 · PMID 42637058 · candidate dictionary pubmed

Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK.

Jiunn Wang, Ricardo Almeida-Magana, Eoin Dinneen et al. · Eur Urol Open Sci · Oct 1, 2026 · PMID 42755911 · candidate dictionary pubmed

Cannabidiol alters the epigenome of hormone-dependent prostate cancer cells.

Joanne Cosgrave, Rianna Magee, Eve O'reilly et al. · Biomed Pharmacother · Oct 1, 2026 · PMID 42691574 · candidate dictionary pubmed

Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer.

Isaac E Kim, Cecile P G Meier-Scherling, Steve R Zhou et al. · Urol Oncol · Oct 1, 2026 · PMID 42674923 · candidate dictionary pubmed

An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial.

Liam Bourke, Derek J Rosario, Sophie Reale et al. · Lancet Oncol · Oct 1, 2026 · PMID 42697217 · candidate dictionary pubmed

Follistatin drives AR-independent prostate cancer through BMP signaling inactivation and microenvironmental remodeling.

Xiaoxian Shi, Zuyan Fan, Min Qu et al. · Proc Natl Acad Sci U S A · Sep 29, 2026 · PMID 42784510 · candidate dictionary pubmed

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation.

J Gómez Rivas, L Fernández Hernández, L Turpin et al. · World J Urol · Sep 29, 2026 · PMID 42809049 · candidate dictionary pubmed

Comparison of deformable image registration algorithms for planning CT and CBCT in prostate cancer patients treated with external beam radiation therapy.

Hussam H Jassim, Nooshin Banaee, Hassan Ali Nedaei et al. · Radiol Phys Technol · Sep 29, 2026 · PMID 42809030 · candidate dictionary pubmed

Image-based Detection of Mismatch Repair Deficiency in Prostate Cancer Using Transfer Learning.

Lucas J Liu, Ruth Etzioni, Haoyue Zhang et al. · Clin Cancer Res · Sep 29, 2026 · PMID 42808876 · candidate dictionary pubmed

Letter: Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison With MRI.

Andrea Ponsiglione, Giorgio Brembilla, Jelle Barentsz · J Urol · Sep 29, 2026 · PMID 42808354 · candidate dictionary pubmed

Theranostics in the management of prostate cancer: from concept to clinical practice.

Kannan Sridharan, Teresa Alonso-Gordoa, Gowri Sivaramakrishnan et al. · Expert Rev Clin Pharmacol · Sep 29, 2026 · PMID 42770599 · candidate dictionary pubmed

Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

Avirup Guha, Ana Barac, Michael James Ryan et al. · JCO Oncol Pract · Sep 28, 2026 · PMID 42804714 · candidate dictionary pubmed

Prostate Cancer Screening and Likelihood of Benefit in Veterans Affairs and Fee-for-Service Medicare.

Alex K Bryant, Adam VanDeusen, Mandi L Klamerus et al. · JAMA Intern Med · Sep 28, 2026 · PMID 42804174 · candidate dictionary pubmed

Does Positive Margin in Secondary Tumors at Radical Prostatectomy Predict Biochemical Recurrence in Multifocal Prostate Cancer?

Nikunj B Shah, Angelica Menendez, Sanoj Punnen et al. · Am J Surg Pathol · Sep 28, 2026 · PMID 42802667 · candidate dictionary pubmed

Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.

Francesco Mattana, Stefano Luzzago, Valentino Dragonetti et al. · Eur J Nucl Med Mol Imaging · Sep 28, 2026 · PMID 42802268 · candidate dictionary pubmed